Related Experiment Video
Updated: Jun 18, 2026

Clarifying and Imaging Candida albicans Biofilms
Published on: March 6, 2020
Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
Lucia Černáková1, Maryam Roudbary2, Susana Brás3
1Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia.
Abstract:
Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has a high rate of multidrug resistance and the occurrence of misleading identifications, and the ability of forming biofilms (naturally more resistant to drugs) has made treatments of C. auris infections highly difficult. This review intends to quickly illustrate the main issues in C. auris identification, available treatments and the associated mechanisms of resistance, and the novel and alternative treatment and drugs (natural and synthetic) that have been recently reported.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Rapid Identification of Pathogens
Cryptococcal Meningitis
Candidiasis
Clinical Significance of Antibiotic Resistance

